Status:
UNKNOWN
COVID-19 Vaccine Response in Chronic Respiratory Conditions
Lead Sponsor:
National Jewish Health
Conditions:
SARS-CoV Infection
Eligibility:
All Genders
18+ years
Brief Summary
The investigators will assess the antibody, T cell and B cell responses to SARS-CoV-2 vaccination before and every 3 months for 18 months after the initial vaccination or subsequent vaccinations (boos...
Detailed Description
HYPOTHESES 1. Patients with chronic respiratory diseases will have a lower antibody response to SARS-CoV-2 virus after vaccination and shorter durability of the response than control subjects without...
Eligibility Criteria
Inclusion
- Receipt of a SARS-CoV-2 vaccination
Exclusion
- None
Key Trial Info
Start Date :
February 3 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT05313087
Start Date
February 3 2021
End Date
December 30 2024
Last Update
April 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Jewish Health
Denver, Colorado, United States, 80206